Back to Search
PRZEMYSLAW TWARDOWSKI, MD
MD
Medical Oncology Physician
NPI: 1942317987IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
A66171(CA)
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
A66171(CA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
A66171(CA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
UNIVERSITY OF MISSOURI, KANSAS CITY, SCHOOL OF MEDICINE
Class of 1996
Research & Publications (20)
Bevacizumab plus interferon alpha in patients with metastatic renal cell carcinoma.
PMID 18560387·Nat Clin Pract Oncol·2008
8-other
Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.
PMID 18181046·Cancer Invest·2008
3-trial
What are the indications for sorafenib treatment in patients with renal cell carcinoma?
PMID 17579598·Nat Clin Pract Oncol·2007
8-other
Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
PMID 19661346·Anticancer Res·2009
3-trial
Influence of promethazine on cardiac repolarisation: a double-blind, midazolam-controlled study.
PMID 19453313·Anaesthesia·2009
2-rct
A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study.
PMID 19396016·Anticancer Drugs·2009
3-trial
Effects of thoracic epidural anaesthesia on cardiac repolarization.
PMID 19298541·Clin Exp Pharmacol Physiol·2009
8-other
Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial.
PMID 19213668·Clin Genitourin Cancer·2009
3-trial
The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trial.
PMID 18272025·Clin Genitourin Cancer·2007
3-trial
Prostate cancer. Clinical practice guidelines in oncology.
PMID 17692170·J Natl Compr Canc Netw·2007
6-review
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity.
PMID 17317834·Clin Cancer Res·2007
3-trial
A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases.
PMID 16533781·Clin Cancer Res·2006
3-trial
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
PMID 16275593·Biol Blood Marrow Transplant·2005
3-trial
Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial.
PMID 15711184·Anticancer Drugs·2005
3-trial
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
PMID 15173955·Cancer Chemother Pharmacol·2004
3-trial
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.
PMID 15143076·J Clin Oncol·2004
8-other
Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial.
PMID 15139054·Cancer·2004
3-trial
A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancer.
PMID 14871968·Clin Cancer Res·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2121 SANTA MONICA BLVD
SANTA MONICA, CA 90404 - Phone
- (310) 582-7137
Quick Facts
- NPI
- 1942317987
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile